Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2004 1
2005 4
2006 4
2007 2
2008 2
2009 5
2010 1
2011 13
2012 5
2013 7
2014 3
2015 5
2016 3
2017 4
2018 2
2019 3
2020 2
2021 4
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

60 results
Results by year
Filters applied: . Clear all
Page 1
Clinical management of grade III oligodendroglioma.
Simonetti G, Gaviani P, Botturi A, Innocenti A, Lamperti E, Silvani A. Simonetti G, et al. Among authors: gaviani p. Cancer Manag Res. 2015 Jul 27;7:213-23. doi: 10.2147/CMAR.S56975. eCollection 2015. Cancer Manag Res. 2015. PMID: 26251628 Free PMC article. Review.
Bevacizumab at recurrence in high-grade glioma.
Salmaggi A, Gaviani P, Botturi A, Lamperti E, Simonetti G, Ferrari D, Silvani A. Salmaggi A, et al. Among authors: gaviani p. Neurol Sci. 2011 Nov;32 Suppl 2:S251-3. doi: 10.1007/s10072-011-0799-6. Neurol Sci. 2011. PMID: 21987287 Review.
Infections in neuro-oncology.
Gaviani P, Silvani A, Lamperti E, Botturi A, Simonetti G, Milanesi I, Ferrari D, Salmaggi A. Gaviani P, et al. Neurol Sci. 2011 Nov;32 Suppl 2:S233-6. doi: 10.1007/s10072-011-0803-1. Neurol Sci. 2011. PMID: 22002073
MRI in treatment of adult gliomas.
Henson JW, Gaviani P, Gonzalez RG. Henson JW, et al. Among authors: gaviani p. Lancet Oncol. 2005 Mar;6(3):167-75. doi: 10.1016/S1470-2045(05)01767-5. Lancet Oncol. 2005. PMID: 15737833 Review.
Safety of bevacizumab in patients with malignant gliomas: a systematic review.
Simonetti G, Trevisan E, Silvani A, Gaviani P, Botturi A, Lamperti E, Beecher D, Bertero L, Bosa C, Salmaggi A. Simonetti G, et al. Among authors: gaviani p. Neurol Sci. 2014 Jan;35(1):83-9. doi: 10.1007/s10072-013-1583-6. Epub 2013 Nov 27. Neurol Sci. 2014. PMID: 24281944 Free article. Review.
Medulloblastoma of the adult: results from a multicenter retrospective study by AINO (Italian Association of Neuro-Oncology) and SIN (Italian Society of Neurology).
Gaviani P, Simonetti G, Rudà R, Franchino F, Lombardi G, Possanzini M, Squintu S, Villani V, Teriaca M, Cavallieri F, Caffo M, Salmaggi A, Bianco A, Anghileri E, Farinotti M, Tramacere I, Silvani A. Gaviani P, et al. Neurol Sci. 2021 Feb;42(2):665-671. doi: 10.1007/s10072-020-04556-6. Epub 2020 Jul 11. Neurol Sci. 2021. PMID: 32654010
Adjuvant chemotherapy after severe myelotoxicity during chemoradiation phase in malignant gliomas. Is it feasibile? Results from AINO study (Italian Association for Neuro-Oncology).
Villani V, Anghileri E, Prosperini L, Lombardi G, Rudà R, Gaviani P, Rizzato S, Lanzetta G, Fabi A, Scaringi C, Pronello E, Simonetti G, Targato G, Pace A. Villani V, et al. Among authors: gaviani p. J Neurol. 2021 Aug;268(8):2866-2875. doi: 10.1007/s00415-021-10438-4. Epub 2021 Feb 20. J Neurol. 2021. PMID: 33609154
60 results